Leaderboard

En | De
No articles selected!     View Cart  
You are here: Dermatology » Skin Neoplasms » Melanoma 27. November 2025
Search
medline.ch
Melanoma
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Melanoma
Others
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2213  Previews Next
   
   Articles 1 - 20 / 44249  
   
Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma.
Curr Oncol
Wang YS, Wang QY, Moise AE, Syed HC, Malo J, Soberano S, Belkaid W, Messaoudene M, Bélanger K, Desilets A, Jamal R, Routy B, Elkrief A.
PMID: 41294692 [PubMed - indexed for MEDLINE]


Insights into shape of uveal melanoma: a comprehensive evaluation of clinical features, pathological features, and prognosis analysis.
Front Med (Lausanne)
Lou H, Yue H, Qian J, Bi Y, Lin X, Chen H, Xu B, Ma R, Xue K, Guo J.
PMID: 41293718 [PubMed]


Global Burden of Non-Melanoma Skin Cancer Among Elder Adults and Projections to 2071: A Systematic and Comprehensive Analysis of the Global Burden of Disease Study 2021.
Clin Cosmet Investig Dermatol
Wang C, Du Z, Tan Y, Yang Z, Hua J, Wang G, Li T.
PMID: 41293322 [PubMed]


Serum lactate dehydrogenase and rapidly progressive interstitial lung disease are associated with increased mortality in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Front Immunol
Wang G, Yan D, Zhang Y, Liu C, Liu Z.
PMID: 41293179 [PubMed - indexed for MEDLINE]


Impact of comorbidities on survival in melanoma patients.
BMC Cancer
Buja A, Cassalia F, Rugge M, Trevisiol C, Zorzi M, Del Fiore P, Pantaleo I, Rossi CR, Conte P, Belloni Fortina A, Mocellin S.
PMID: 41291616 [PubMed - as supplied by publisher]


Neoadjuvant plus adjuvant dabrafenib and trametinib versus adjuvant dabrafenib and trametinib in patients with stage III melanoma: a single-center retrospective cohort study.
J Dermatolog Treat
Jia DD, Li T.
PMID: 41290590 [PubMed - indexed for MEDLINE]


"Response to Factors associated with adherence to skin self-examination recommendations for melanoma patients: a prospective cohort study".
J Am Acad Dermatol
Gill M, Yang S, Kim D, Babaei N, Cervantes M, Wu JJ.
PMID: 41285263 [PubMed - as supplied by publisher]


Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study.
Eur J Epidemiol
Rietz Liljedahl E, Nielsen K, Engfeldt M, Saxne Jöud A, Nielsen C.
PMID: 41284183 [PubMed - as supplied by publisher]


Is Radiotherapy a Risk Factor for Melanoma?
Dermatopathology (Basel)
Ozer S, Agarwal P, Musolff N, Plann-Curley B, Cosgun G, Sun HY, Rao B.
PMID: 41283485 [PubMed]


Translating Features to Findings: Deep Learning for Melanoma Subtype Prediction.
Dermatopathology (Basel)
Guermazi D, Khemchandani S, Wahood S, Nguyen C, Saliba E.
PMID: 41283484 [PubMed]


The mediating role of rumination between fear of disease progression and sleep disturbance in melanoma patients: a dual-perspective analysis based on person-centered and variable-centered approaches.
Front Public Health
Huang Q, Yue F, Shi W, Lei Y, Jiang T.
PMID: 41283030 [PubMed - indexed for MEDLINE]


Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
medRxiv
Karapetyan L, Cillo AR, Wang S, Karunamurthy A, Massa RC, Rohatgi A, Deitrick C, Najjar YG, Davar D, Luke JJ, Sander C, Kunning SR, Rose A, Bradley S, Rush E, Joy M, Bao R, Wang H, Vignali DAA, Bruno TC, Kirkwood JM.
PMID: 41282765 [PubMed]


Deep learning [(18)F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy.
Clin Transl Radiat Oncol
Faro LL, Gabry, Burgermeister S, Abler D, Fritsak M, Ahmadsei M, Franzese C, Depeursinge A, Cuendet MA, Tanadini-Lang S, Balermpas P, Scorsetti M, Guckenberger M, Christ SM.
PMID: 41281625 [PubMed]


Navigating the Rare: (18)F FDG PET/CT Reveals Uterine Metastasis from Cutaneous Melanoma.
Indian J Nucl Med
Subramani R, Selvam V, Singh V, Abhilash S.
PMID: 41281177 [PubMed]


Iron oxide nanoparticles empowering melanoma therapy: advances in multifunctional platform research.
Front Bioeng Biotechnol
Bai X, Wang Z, Cao Z, Zhen J.
PMID: 41280655 [PubMed]


Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024.
J Eur Acad Dermatol Venereol
Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T.
PMID: 41277769 [PubMed - as supplied by publisher]


Disparities in Cutaneous Melanoma Diagnosis and Survival Among American Indian and Alaskan Native Patients: A Systematic Review and Meta-Analysis.
J Surg Oncol
Li RA, Nguyen AT, Bajaj K, Coles BM, Galiano RD.
PMID: 41277703 [PubMed - as supplied by publisher]


The application of 3D cell culture for melanoma in vitro models.
Acta Biomater
Xu K, Wu J, Li Z, Chen W, Wei P, Wu M.
PMID: 41275949 [PubMed - as supplied by publisher]


Cellular senescence related gene signature predicts prognosis and immune features in skin cutaneous melanoma.
Discov Oncol
Li M, Cen X, Yan Y, Li L, Lai W.
PMID: 41275062 [PubMed - as supplied by publisher]


Sex and gender influence on adverse events for melanoma patients: a comprehensive review and meta-analysis.
Br J Cancer
Gaeta A, Nuvoli L, Doccioli C, Caini S, Saponara M, Cimminiello C, Cosma C, Palmieri G, Cossu A, Vicini F, Mazzarella L, Tosti G, Queirolo P, Gandini S.
PMID: 41275011 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 44249    Page 1 of 2213  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1